Inderma Md
FDA Label NDC 54723-009
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sambria Pharmaceuticals, Llc for the product Inderma Md (NDC 54723-009). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, active ingredient, purpose, uses, warnings, keep out of reach of children, directions, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient
Benzocaine 20%
Purpose
External Analgesic
Uses
For temporary relief of pain and itching due to minor skin irritation.
Warnings
For external use only
Avoid contact with eyes
Do not use in large quantities, particularly over raw surfaces or blistered areas
Stop use and ask a doctor if
• Condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Discontinue use.
Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
For adults and children two-years or older: Apply to affected area not more than 3 or 4 times
daily. Children under 2 years of age: consult a physician. Apply in a circular motion for 30 to 60 seconds.
Inactive Ingredients
Aqua (Deionized Water), Arnica Montana Flower Extract, C13-14 Isoparaffin, Chrondroitin Sulfate,
Emu Oil, Ethoxydiglycol, Ethylhexyglycerin, Glucosamine Sulfate, Isopropyl Palmitate, Laureth-7, Melaleuca Alternifolia (Tea Tree) Oil, Methylsulfonylmethane (MSM), Phenoxyethanol, Polyacrylamide, Propylene Glycol, Stearic Acid, Triethanolamine.
Other Information
Protect this product from excessive heat and direct sun.
Questions And Comments?
Product Label
Image Description (Benzocane Image 1)
* Please review the disclaimer below.
